Call Options

25 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$58.53 - $68.82 $70,236 - $82,583
-1,200 Reduced 9.38%
11,600 $738,000
Q1 2024

May 07, 2024

BUY
$54.2 - $69.69 $157,180 - $202,101
2,900 Added 29.29%
12,800 $884,000
Q4 2023

Feb 14, 2024

SELL
$48.72 - $65.43 $199,752 - $268,263
-4,100 Reduced 29.29%
9,900 $545,000
Q3 2023

Nov 14, 2023

BUY
$50.28 - $64.61 $221,232 - $284,284
4,400 Added 45.83%
14,000 $812,000
Q2 2023

Aug 11, 2023

BUY
$37.29 - $53.83 $29,832 - $43,064
800 Added 9.09%
9,600 $516,000
Q1 2023

May 16, 2023

SELL
$37.61 - $45.72 $372,339 - $452,628
-9,900 Reduced 52.94%
8,800 $349,000
Q4 2022

Feb 14, 2023

SELL
$31.9 - $41.95 $28,710 - $37,755
-900 Reduced 4.59%
18,700 $752,000
Q3 2022

Nov 14, 2022

BUY
$29.83 - $38.01 $119,320 - $152,040
4,000 Added 25.64%
19,600 $630,000
Q2 2022

Aug 15, 2022

SELL
$23.09 - $33.46 $73,888 - $107,072
-3,200 Reduced 17.02%
15,600 $463,000
Q1 2022

May 16, 2022

SELL
$26.91 - $47.15 $522,054 - $914,710
-19,400 Reduced 50.79%
18,800 $528,000
Q4 2021

Feb 14, 2022

BUY
$32.97 - $56.85 $979,209 - $1.69 Million
29,700 Added 349.41%
38,200 $1.76 Million
Q3 2021

Nov 15, 2021

BUY
$26.48 - $35.99 $66,200 - $89,975
2,500 Added 41.67%
8,500 $279,000
Q2 2021

Aug 11, 2021

SELL
$31.86 - $38.6 $140,184 - $169,840
-4,400 Reduced 42.31%
6,000 $210,000
Q1 2021

May 17, 2021

SELL
$28.4 - $36.14 $272,640 - $346,944
-9,600 Reduced 48.0%
10,400 $376,000
Q1 2020

May 15, 2020

BUY
$30.35 - $67.14 $78,910 - $174,564
2,600 Added 14.94%
20,000 $815,000
Q4 2019

Feb 14, 2020

BUY
$55.65 - $79.83 $127,995 - $183,609
2,300 Added 15.23%
17,400 $1.07 Million
Q3 2019

Nov 14, 2019

SELL
$64.7 - $85.39 $951,090 - $1.26 Million
-14,700 Reduced 49.33%
15,100 $1.1 Million
Q2 2019

Aug 14, 2019

BUY
$67.77 - $82.2 $386,289 - $468,540
5,700 Added 23.65%
29,800 $2.45 Million
Q1 2019

May 15, 2019

BUY
$45.83 - $70.54 $563,709 - $867,642
12,300 Added 104.24%
24,100 $1.7 Million
Q4 2018

Feb 14, 2019

SELL
$41.17 - $56.44 $193,499 - $265,268
-4,700 Reduced 28.48%
11,800 $531,000
Q3 2018

Nov 14, 2018

SELL
$52.95 - $71.34 $2.45 Million - $3.3 Million
-46,200 Reduced 73.68%
16,500 $933,000
Q2 2018

Aug 14, 2018

SELL
$56.38 - $68.08 $1.22 Million - $1.47 Million
-21,600 Reduced 25.62%
62,700 $4.19 Million
Q1 2018

May 15, 2018

BUY
$56.98 - $72.41 $2.5 Million - $3.17 Million
43,800 Added 108.15%
84,300 $4.91 Million
Q4 2017

Feb 14, 2018

BUY
$53.3 - $74.56 $1.22 Million - $1.71 Million
22,900 Added 130.11%
40,500 $2.61 Million
Q3 2017

Nov 14, 2017

BUY
$43.46 - $52.49 $764,896 - $923,824
17,600
17,600 $924,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.02B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.